Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.8K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

5.3K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.3K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.9K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.9K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Future concepts in bronchodilation for COPD: dual- <i>versus</i> monotherapy.

European respiratory review : an official journal of the European Respiratory Society·2021
Same author

Comparative Impact of Depressive Symptoms and FEV<sub>1</sub>% on Chronic Obstructive Pulmonary Disease.

Annals of the American Thoracic Society·2021
Same author

A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial.

The European respiratory journal·2021
Same author

Barriers to antigen detection and avoidance in chronic hypersensitivity pneumonitis in the United States.

Respiratory research·2021
Same author

Identifying organ dysfunction trajectory-based subphenotypes in critically ill patients with COVID-19.

Scientific reports·2021
Same author

Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial.

ERJ open research·2021

Related Experiment Video

Updated: Feb 17, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.6K

Lung function trajectories and chronic obstructive pulmonary disease: current understanding and knowledge gaps.

Jamuna K Krishnan1, Fernando J Martinez

  • 1Division of Pulmonary and Critical Care Medicine, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College, New York, New York, USA.

Current Opinion in Pulmonary Medicine
|December 6, 2017
PubMed
Summary

Understanding lung function in chronic obstructive pulmonary disease (COPD) is key. Early identification of factors influencing lung function and decline can lead to targeted therapies for better outcomes.

More Related Videos

Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling
05:47

Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling

Published on: February 12, 2019

22.1K
Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
06:22

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

547

Related Experiment Videos

Last Updated: Feb 17, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.6K
Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling
05:47

Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling

Published on: February 12, 2019

22.1K
Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
06:22

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

547

Area of Science:

  • Pulmonary Medicine
  • Respiratory Research

Background:

  • Chronic obstructive pulmonary disease (COPD) exhibits significant patient heterogeneity in lung function.
  • Lung function trajectories vary, impacting disease progression and outcomes.

Purpose of the Study:

  • Review recent advances in understanding COPD lung function trajectories.
  • Focus on factors influencing peak lung function, decline markers, and early pharmacologic interventions.

Main Methods:

  • Analysis of population-based studies and recent clinical trial data.
  • Review of factors affecting maximal lung function and decline.
  • Evaluation of pharmacologic interventions in early COPD.

Main Results:

  • Lower early-life lung function predicts lower adult forced expiratory volume in 1 second (FEV1).
  • Childhood exposures and smoking impact maximal lung function; symptoms like mucous hypersecretion correlate with decline.
  • Tiotropium and fluticasone showed slower FEV1 decline in clinical trials.

Conclusions:

  • Identifying individuals at risk for low maximal lung function and accelerated decline is crucial.
  • Precision medicine approaches with early targeted therapies can modify COPD activity and outcomes.